SCHEMBL1961141

SCHEMBL1961141

Cc1nc(-c2nn(-c3ccc(F)cc3)cc2Sc2ccc(Cl)cc2)cnc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.61
KCNH2 Q12809 3/20 0.61
KMT2A Q03164 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MAPT P10636 1/20 0.35
UBE2N P61088 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CDK2 P24941 2/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.34
NR3C1 P04150 1/20 0.34
PTGS2 P35354 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
RHEB Q15382 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1963411 0.89 FAAH (0.49) FAAHKCNH2RXFP1MAPTMAPK1
SCHEMBL15016236 0.89 FAAH (0.49) FAAHKCNH2RXFP1LMNAMAPK1
SCHEMBL15016219 0.83 FAAH (0.68) FAAHKCNH2KMT2AMAPTUBE2N
SCHEMBL8001300 0.82 FAAH (0.73) FAAHKCNH2RXFP1MAPTL3MBTL1
SCHEMBL1961329 0.81 FAAH (0.49) FAAHKCNH2KMT2ARXFP1LMNA
SCHEMBL12551879 0.80 FAAH (0.70) FAAHKCNH2KMT2ARXFP1MAPT
SCHEMBL1964390 0.79 KMT2A (0.41) FAAHKCNH2KMT2AMAPTL3MBTL1
SCHEMBL1535331 0.78 FAAH (0.67) FAAHKCNH2KMT2AMAPTUBE2N
SCHEMBL1961136 0.78 FAAH (0.67) FAAHKCNH2MAPTUBE2NL3MBTL1
SCHEMBL1961135 0.78 FAAH (0.67) FAAHKCNH2KMT2AMAPTUBE2N

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP claimed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US claimed
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP disclosed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HRH2 FAAH 1/4885KCNH2 930/4885KMT2A 1541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.